N-PORT filing recap · May 2025
What did Torray Equity Income Fund buy in May 2025?
Reported stock-position changes between this filing and the previous one. These are Torray Equity Income Fund's own holdings, not the firm's.
Stock value
$284.17M
Positions
21
Estimated turnover
80.2%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Torray Equity Income Fund opened new positions in Broadcom, Blackstone, Cna Financial, Abbvie, Pfizer, Prologis, and Chevron. It exited Alphabet, Fiserv, Hewlett Packard Enterprise, Johnson & Johnson, Keysight Technologies, Qualcomm, Slb Limited, and Ulta Beauty. The fund substantially increased its stakes in Texas Instruments, Phillips 66, and UnitedHealth Group, while substantially reducing W. R. Berkley. It also trimmed Berkshire Hathaway and Marsh & Mclennan, and added to Home Depot and Amgen.